newsfilter
← Latest News
PR Newswire·

Neurocrine Biosciences Reports Second-Quarter 2026 Financial Results

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the second quarter ended June 30, 2026. "Our second quarter...